Short Interest in GlobeStar Therapeutics Co. (OTCMKTS:GSTC) Increases By 934.4%

GlobeStar Therapeutics Co. (OTCMKTS:GSTC) was the recipient of a significant increase in short interest in March. As of March 15th, there was short interest totalling 33,100 shares, an increase of 934.4% from the February 28th total of 3,200 shares. Based on an average trading volume of 1,865,900 shares, the short-interest ratio is currently 0.0 days. Currently, 0.0% of the company’s shares are short sold.

GlobeStar Therapeutics Trading Up 50.0 %

GSTC opened at $0.00 on Friday. GlobeStar Therapeutics has a 1 year low of $0.00 and a 1 year high of $0.00.

GlobeStar Therapeutics Company Profile

GlobeStar Therapeutics Corporation, a clinical stage pharmaceutical company, focuses on developing a patented formulation of drugs for the treatment of multiple sclerosis and other neurodegenerative diseases. It offers Amethyst, a compound intended to treat neurodegeneration. The company was formerly known as AngioSoma, Inc and changed its name to GlobeStar Therapeutics Corporation in July 2021.